428
Views
4
CrossRef citations to date
0
Altmetric
Clinical Focus: Neurological & Psychiatric Disorders - Original Research

Aiginition Longitudinal Biomarker Investigation Of Neurodegeneration (ALBION): study design, cohort description, and preliminary data

, , , , , , , , , , & show all
Pages 501-508 | Received 11 Jun 2019, Accepted 01 Sep 2019, Published online: 16 Sep 2019

References

  • Winblad B, Amouyel P, Andrieu S, et al. Defeating Alzheimer’s disease and other dementias: a priority for European science and society. Lancet Neurol. 2016 Apr;15(5):455–532.
  • Dubois B, Hampel H, Feldman HH, et al. Preclinical Alzheimer’s disease: definition, natural history, and diagnostic criteria. Alzheimer’s Dementia. 2016 Mar;12(3):292–323.
  • Jack CR Jr., Knopman DS, Jagust WJ, et al. Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013 Feb;12(2):207–216.
  • Jack CR Jr., Bennett DA, Blennow K, et al. A/T/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology. 2016 Aug 2;87(5):539–547.
  • Arenaza-Urquijo EM, Wirth M, Chetelat G. Cognitive reserve and lifestyle: moving towards preclinical Alzheimer’s disease. Front Aging Neurosci. 2015;7:134.
  • Brown BM, Peiffer JJ, Taddei K, et al. Physical activity and amyloid-beta plasma and brain levels: results from the Australian imaging, biomarkers and lifestyle study of ageing. Mol Psychiatry. 2013 Aug;18(8):875–881.
  • Soldan A, Pettigrew C, Fagan AM, et al. ATN profiles among cognitively normal individuals and longitudinal cognitive outcomes. Neurology. 2019 Apr 2;92(14):e1567–e1579.
  • Solomon A, Kivipelto M, Molinuevo JL, et al. European Prevention of Alzheimer’s Dementia Longitudinal Cohort Study (EPAD LCS): study protocol. BMJ Open. 2019 Feb 19;8(12):e021017.
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders. revised 4th ed. Washington, DC: American Psychiatric Association; 2000.
  • McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer’s Disease. Neurology. 1984 Jul;34(7):939–944.
  • Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol. 2001 Dec;58(12):1985–1992.
  • Hachinski VC, Iliff LD, Zilhka E, et al. Cerebral blood flow in dementia. Arch Neurol. 1975 Sep;32(9):632–637.
  • Michopoulos I, Douzenis A, Kalkavoura C, et al. Hospital Anxiety and Depression Scale (HADS): validation in a Greek general hospital sample. Ann Gen Psychiatry. 2008 Mar 6;7:4.
  • Vlachos GS, Cosentino S, Kosmidis MH, et al. Prevalence and determinants of subjective cognitive decline in a representative Greek elderly population. Int J Geriatr Psychiatry. 2019 Jun;34(6):846–854.
  • Margioti E, Kosmidis MH, Yannakoulia M, et al. Exploring the association between subjective cognitive decline and frailty: the Hellenic Longitudinal Investigation of Aging and Diet Study (HELIAD). Aging Ment Health. 2019;9:1–11.
  • Tsapanou A, Vlachos GS, Cosentino S, et al. Sleep and subjective cognitive decline in cognitively healthy elderly: results from two cohorts. J Sleep Res. 2018;28(5):e12759.
  • Adams JD, Kavouras SA, Robillard JI, et al. Fluid balance of adolescent swimmers during training. J Strength Cond Res. 2016 Mar;30(3):621–625.
  • Hays RD, Martin SA, Sesti AM, et al. Psychometric properties of the Medical Outcomes Study Sleep measure [Evaluation StudiesResearch Support, N.I.H., ExtramuralResearch Support, U.S. Gov’t, P.H.S.Validation Studies]. Sleep Med. 2005 Jan;6(1):41–44.
  • Martin JL, Hakim AD. Wrist actigraphy. Chest. 2011 Jun;139(6):1514–1527.
  • Morgenthaler T, Alessi C, Friedman L, et al. Practice parameters for the use of actigraphy in the assessment of sleep and sleep disorders: an update for 2007. Sleep. 2007 Apr;30(4):519–529.
  • Choi JH, Lee B, Lee JY, et al. Validating the watch-PAT for diagnosing obstructive sleep apnea in adolescents. J Clin Sleep Med. 2018 Oct 15;14(10):1741–1747.
  • Buchman AS, Boyle PA, Wilson RS, et al. Association between late-life social activity and motor decline in older adults. Arch Internal Med. 2009 Jun 22;169(12):1139–1146.
  • Mendes de Leon CF, TA G, Berkman LF. Social engagement and disability in a community population of older adults: the New Haven EPESE [Research Support, U.S. Gov’t, P.H.S.]. Am J Epidemiol. 2003 Apr 1;157(7):633–642.
  • Wilson RS, Bennett DA, Beckett LA, et al. Cognitive activity in older persons from a geographically defined population [Research Support, U.S. Gov’t, P.H.S.]. J Gerontol B Psychol Sci Soc Sci. 1999 May;54(3):P155–60.
  • Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969 Autumn;9(3):179–186.
  • Kavouras S, Maraki M, Kollia M, et al. Development, reliability and validity of a physical activity questionnaire for estimating energy expenditure in Greek adults. Sci Sports. 2016;31(3):e47–e53.
  • Buchman AS, Wilson RS, Boyle PA, et al. Grip strength and the risk of incident Alzheimer’s disease. Neuroepidemiology. 2007;29(1–2):66–73.
  • Willey JZ, Scarmeas N, Provenzano FA, et al. White matter hyperintensity volume and impaired mobility among older adults [Research Support, N.I.H., Extramural]. J Neurol. 2013 Mar;260(3):884–890.
  • Conway JM, Ingwersen LA, Moshfegh AJ. Accuracy of dietary recall using the USDA five-step multiple-pass method in men: an observational validation study. J Am Diet Assoc. 2004 Apr;104(4):595–603.
  • Conway JM, Ingwersen LA, Vinyard BT, et al. Effectiveness of the US department of agriculture 5-step multiple-pass method in assessing food intake in obese and nonobese women. Am J Clin Nutr. 2003 May;77(5):1171–1178.
  • Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189–198.
  • Mioshi E, Dawson K, Mitchell J, et al. The Addenbrooke’s Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry. 2006 Nov;21(11):1078–1085.
  • Lezak MD, Howieson DB, Loring DW, et al. Neuropsychological assessment. Oxford University Press, USA; 2004.
  • Vlahou CH, Kosmidis MH, Dardagani A, et al. Development of the Greek verbal learning test: reliability, construct validity, and normative standards. Arch Clin Neuropsychol. 2013 Feb;28(1):52–64.
  • Vlahou C, Kosmidis M. The Greek trail making test: preliminary normative data for clinical and research use. Psychology. 2002;9:336–352.
  • Blackburn DJ, Zhao Y, De Marco M, et al. A pilot study investigating a novel non-linear measure of eyes open versus eyes closed eeg synchronization in people with Alzheimer’s disease and healthy controls. Brain Sci. 2018 Jul 17;8(7):134.
  • Teunissen CE, Tumani H, Engelborghs S, et al. Biobanking of CSF: international standardization to optimize biomarker development. Clin Biochem. 2014 Mar;47(4–5):288–292.
  • Sinha R, Chen J, Amir A, et al. Collecting fecal samples for microbiome analyses in Epidemiology studies. Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):407–416.
  • Vogtmann E, Chen J, Amir A, et al. Comparison of collection methods for fecal samples in Microbiome studies. Am J Epidemiol. 2017 Jan 15;185(2):115–123.
  • Riegler G, Esposito I. Bristol scale stool form. A still valid help in medical practice and clinical research. Tech Coloproctol. 2001 Dec;5(3):163–164.
  • Epelbaum S, Genthon R, Cavedo E, et al. Preclinical Alzheimer’s disease: A systematic review of the cohorts underlying the concept. Alzheimer’s Dementia. 2017 Apr;13(4):454–467.
  • Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s Dementia. 2011 May;7(3):280–292.
  • Tan CC, Yu JT, Tan L. Biomarkers for preclinical Alzheimer’s disease. J Alzheimers Dis. 2014;42(4):1051–1069.
  • Chen WP, Samuraki M, Yanase D, et al. Effect of sample size for normal database on diagnostic performance of brain FDG PET for the detection of Alzheimer’s disease using automated image analysis. Nucl Med Commun. 2008 Mar;29(3):270–276.
  • Devanand DP, Liu X, Brown PJ, et al. A two-study comparison of clinical and MRI markers of transition from mild cognitive impairment to Alzheimer’s disease. Int J Alzheimer’s Dis. 2012;2012:483469.
  • Dobert N, Pantel J, Frolich L, et al. Diagnostic value of FDG-PET and HMPAO-SPET in patients with mild dementia and mild cognitive impairment: metabolic index and perfusion index. Dement Geriatr Cogn Disord. 2005;20(2–3):63–70.
  • Li R, Wu X, Fleisher AS, et al. Attention-related networks in Alzheimer’s disease: a resting functional MRI study. Hum Brain Mapp. 2012 May;33(5):1076–1088.
  • Olsson B, Lautner R, Andreasson U, et al. CSF and blood biomarkers for the diagnosis of Alzheimer’s disease: a systematic review and meta-analysis. Lancet Neurol. 2016 Jun;15(7):673–684.
  • Maestu F, Cuesta P, Hasan O, et al. The Importance of the validation of M/EEG with current biomarkers in Alzheimer’s Disease. Front Hum Neurosci. 2019;13:17.
  • O’Bryant SE, Mielke MM, Rissman RA, et al. Blood-based biomarkers in Alzheimer disease: current state of the science and a novel collaborative paradigm for advancing from discovery to clinic. Alzheimer’s Dementia. 2017 Jan;13(1):45–58.
  • Pena-Bautista C, Roca M, Hervas D, et al. Plasma metabolomics in early Alzheimer’s disease patients diagnosed with amyloid biomarker. J Proteomics. 2019 Apr;9(200):144–152.
  • Su C, Zhao K, Xia H, et al. Peripheral inflammatory biomarkers in Alzheimer’s disease and mild cognitive impairment: a systematic review and meta-analysis. Psychogeriatrics. 2019;19(4):300–309.
  • Pulliam L, Sun B, Mustapic M, et al. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer’s disease. J Neurovirol. 2019;1–8.
  • Kim E, Jung YS, Kim H, et al. Metabolomic signatures in peripheral blood associated with Alzheimer’s disease amyloid-beta-induced neuroinflammation. J Alzheimers Dis. 2014;42(2):421–433.
  • Nakamura A, Kaneko N, Villemagne VL, et al. High performance plasma amyloid-beta biomarkers for Alzheimer’s disease. Nature. 2018 Feb 8;554(7691):249–254.
  • Blennow K. A review of fluid biomarkers for Alzheimer’s disease: moving from CSF to blood. Neurol Ther. 2017 Jul;6(Suppl 1):15–24.
  • Gomez-Eguilaz M, Ramon-Trapero JL, Perez-Martinez L, et al. [The microbiota-gut-brain axis and its great projections]. Rev Neurol. 2019 Feb 1;68(3):111–117.
  • Gareau MG, Wine E, Rodrigues DM, et al. Bacterial infection causes stress-induced memory dysfunction in mice. Gut. 2011 Mar;60(3):307–317.
  • Scullin MK, Bliwise DL. Sleep, cognition, and normal aging: integrating a half century of multidisciplinary research. Perspect Psychol Sci. 2015 Jan;10(1):97–137.
  • Lucey BP, Hicks TJ, McLeland JS, et al. Effect of sleep on overnight cerebrospinal fluid amyloid beta kinetics. Ann Neurol. 2018 Jan;83(1):197–204.
  • Jackowska M, Ronaldson A, Brown J, et al. Biological and psychological correlates of self-reported and objective sleep measures. J Psychosom Res. 2016;84:52–55.
  • Scarmeas N, Anastasiou CA, Yannakoulia M. Nutrition and prevention of cognitive impairment. Lancet Neurol. 2018 Nov;17(11):1006–1015.
  • Freedman LS, Commins JM, Moler JE, et al. Pooled results from 5 validation studies of dietary self-report instruments using recovery biomarkers for energy and protein intake. Am J Epidemiol. 2014 Jul 15;180(2):172–188.
  • Scarmeas N, Levy G, Tang MX, et al. Influence of leisure activity on the incidence of Alzheimer’s disease. Neurology. 2001 Dec 26;57(12):2236–2242.
  • Stephen R, Hongisto K, Solomon A, et al. Physical activity and Alzheimer’s Disease: A systematic review. J Gerontol A Biol Sci Med Sci. 2017 Jun 1;72(6):733–739.
  • Rodriguez-Manas L, Feart C, Mann G, et al. Searching for an operational definition of frailty: a Delphi method based consensus statement: the frailty operative definition-consensus conference project. J Gerontol A Biol Sci Med Sci. 2013 Jan;68(1):62–67.
  • Robertson DA, Savva GM, Kenny RA. Frailty and cognitive impairment–a review of the evidence and causal mechanisms. Ageing Res Rev. 2013 Sep;12(4):840–851.
  • Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146–56.
  • Rockwood K, Mitnitski A. Frailty in relation to the accumulation of deficits. J Gerontol A Biol Sci Med Sci. 2007 Jul;62(7):722–727.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.